Metabolic Dysfunction-Associated Steatohepatitis  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

157 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Metabolic Dysfunction-Associated Steatohepatitis
ChiCTR-IOR-15007206: Effect of yinchen Linggui decoction on NASH based on ultrasonic attenuation parameters

Recruiting
N/A
72
 
yinchenlinguiji versus yishanfu
Dongfang Hospital, Beijing Univetsity of Chinese Medicine; Level of the institution:, Dongfang Hospital, Beijing Univetsity of Chinese Medicine
Nonalcoholic steatohepatitis
 
 
ChiCTR-IOR-14005445: Clinical study of Jianpi Liqi Huashi Decoction on insulin resistance and free fatty acid in nonalcoholic steatohepatitis in patients

Not yet recruiting
N/A
92
 
Jianpi Liqi Huashi decoction ;Placebo (1/10 dosage Jianpi Liqi Huashi decoction)
Infectious Disease Hospital of Pudong New Area Shanghai; Infectious Disease Hospital of Pudong New Area Shanghai, Shanghai Pudong New Area Science and Technology Commission
non-alcoholic steatohepatitis
 
 
NCT02422238: Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease

Recruiting
N/A
500
Europe
Maastricht University Medical Center, Centrum Obesitas-Eetstoornissen (CO-EUR)
Nonalcoholic Fatty Liver Disease
12/17
12/27
ChiCTR-INR-16008014: A study of the therapeutic role of baicalin on non-alcoholic steatohepatitis by down-regulating the expression of miR103/107 and its mechanisms

Recruiting
N/A
240
 
Placebo ;baicalin ;metformin; baicalin plus metformin
the Central Hospital of Qingdao; the Central Hospital of Qingdao, the Central Hospital of Qingdao
non-alcoholic steatohepatitis
 
 
PERSPECTIVE, NCT06523179: Evaluation of Risk of hEpatocellular Carcinoma

Recruiting
N/A
500
Europe
quantify the impact of genetic risk factors
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
NASH, HCC, Genetic Predisposition
01/22
12/25
ChiCTR2100044823: Expanding donor pool for live donor liver transplantation: Utilization of donors with NASH after optimization

Completed
N/A
410
 
No
not applicable; Level of the institution:, no source of support
live liver donors (LLDs) with and without non-alcoholic steatohepatitis
 
 
NAFLD disease registry study, ChiCTR-OOC-16007902: A Clinical Study Evaluating the Association between NASH/Fibrosis and Metabolic

Recruiting
N/A
480
 
NA
Shanghai Xinhua Hospital; Sanofi (Beijing) Pharmaceutical Co., Ltd., Sanofi (Beijing) Pharmaceutical Co., Ltd.
Nonalcoholic fatty liver disease
 
 
NCT06499675: Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based Study

Completed
N/A
272
RoW
sleeve gastrectomy, Liver Biopsy
Egyptian Liver Hospital
Obesity, Obesity, Morbid, Bariatric Surgery Candidate, Steatosis of Liver, Steatohepatitis, Nonalcoholic
12/23
05/24
DIANA, NCT06315361: DIAbetes and NAFLD

Active, not recruiting
N/A
600
Europe
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NAFLD, Diabetes, NASH, Fibrosis, Liver, Cirrhosis, Liver, Liver Cancer
12/35
12/35
ChiCTR1800018629: The combination of diammonium glycyrrhizate enteric capsule and vitamin E can reduce the level of inflammation and degree of liver fibrosis in patients with fatty liver disease

Not yet recruiting
N/A
200
 
There is no drug treatment, and patients are required to strictly control their diet, formulate a professional diet table and exercise strictly ;Diammonium glycyrrhizate enteric capsule 150mg 3/ d, oral, 12 weeks ;Vitamin E 800mg/d, oral, 12 weeks ;Diammonium glycyrrhizate enteric capsule 150mg 3/ d, oral, 12 weeks , Vitamin E 800mg/d, oral, 12 weeks
First Affiliated Hospital, Jilin University; First Affiliated Hospital, Jilin University, First Affiliated Hospital, Jilin University
non-alcoholic steatohepatitis
 
 
ChiCTR1800017879: Vitamin D through Banlancing of Gut Microbiota to Improve Non-alcoholic Steatohepatitis (NASH)

Recruiting
N/A
84
 
Medical treatment+Viamin D: 600,000 IP for the first treatment,and additional 300,000 IU treatment in the following month for total 4 treatments. ;Medical treatment
Public Health and Clinical Center of Chengdu; Public Health and Clinical Center of Chengdu, Liver disease key subjects fund
non-alcoholic steatohepatitis
 
 
NCT06176079: Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease

Recruiting
N/A
80
US
Hyperpolarized (HP) 13C, HP 13C, Hyperpolarized 13C-Urea, HP13C-urea, copol, Magnetic Resonance Imaging, MRI, MR, Saline Flush
Michael Ohliger, MD PhD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Fatty Liver, Non Alcoholic Steatohepatitis, NAFLD, NASH
02/25
02/25
ChiCTR1800015167: Study on the new strategy and key techniques of accurate prevention of nonalcoholic steatohepatitis based on intestinal target bacteria

Recruiting
N/A
60
 
diet and exercise
Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Project subsidy for Social Development Research Initiative design of Hangzhou City
nonalcoholic steatohepatitis
 
 
ChiCTR1800016178: Study on the new strategy and key techniques for accurate prevention and treatment of nonalcoholic steatohepatitis based on intestinal target bacteria

Recruiting
N/A
120
 
Diet
Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Project subsidy for Social Development Research Initiative design of Hangzhou City
nonalcoholic steatohepatitis
 
 
NCT04555434: Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH

Recruiting
N/A
120
RoW
Probiotics, Cellulose (Placebo)
Chuncheon Sacred Heart Hospital
Non-Alcoholic Fatty Liver Disease
09/20
09/20
NALKOSTEP, NCT02792634: Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery

Recruiting
N/A
200
Europe
Sleeve-Gastrectomy, Roux en Y gastric bypass
RWTH Aachen University
Bariatric Surgery Candidate, Nonalcoholic Steatohepatitis, Obesity
12/20
12/22
ChiCTR1900027262: The Mechanism and Clinical Transformation of heme oxygenase-1 on Mitochondrial function in Non-Alcoholic Steatohepatitis

Recruiting
N/A
403
 
Liver biopsy ;Liver biopsy ;Collect blood samples
The Third Hospital of Hebei Medical University; The Third Hospital of Hebei Medical University, National Natural Science Foundation of China (Grant No. 81970504 and 8170030286), Natural Science Foundation of Hebei (Grant No. H2018206326 and H2017206282)
Non-Alcoholic Steatohepatitis
 
 
CONNECT, NCT04653103: NASH in Subjects With Different Classes of Obesity

Active, not recruiting
N/A
500
Europe
Liver biopsy
Catholic University of the Sacred Heart
NASH - Nonalcoholic Steatohepatitis, NAFLD, Obesity, Obesity, Morbid
01/21
01/23
ChiCTR2000034583: Immune inflammation induced by Treg/Th17 imbalance in nonalcoholic steatohepatitis patients and intervention effect of Jiangzhi Granules

Not yet recruiting
N/A
32
 
Jiangzhi Granules
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, National Natural Science Foundation of China
nonalcoholic steatohepatitis
 
 
ChiCTR1800019456: Continous Versus Intermittent Energy Restriction in the Treatment of Non-diabetic Patients with Nonalcoholic Steatohepatitis in China: A Randomized, Open-label, Controlled Trial

Recruiting
N/A
20
 
Daily energy intake as 1600-1700kcal for male patients and 1300-1400kcal for female patients combined with Vitamin E soft gel treatment in a dose of 100mg bid,PO. Continue this management 7 days per week for 24 weeks. ;2 days per week with Daily energy intake as 500-600kcal, and the rest 5 days with normal diet(2250kcal/day for male patients and 1800kcal/day for female patients) combined with Vitamin E soft gel treatment in a dose of 100mg bid,PO. Continue this for 24 weeks.
the First Affiliated Hospital of Wenzhou Medical University; the First Affiliated Hospital of Wenzhou Medical University, High Level Creative Talents from Department of Public Health in Zhejiang Province
Non-diabetic Patients with Nonalcoholic Steatohepatitis
 
 
NashGp73, ChiCTR1800015157: Performance of GP73 for diagnosing NASH in population with NAFLD

Not yet recruiting
N/A
 
Beijing Ditan Hospital, Capital Medical University; Beijing Municipal Science & Technology Commission, Capital Foundation for Clinical Characteristic Applied Research Projects
Non-alcoholic fatty liver disease
 
 
SepsisFAT, NCT04573543: The Role of Immune Semaphorins in NAFLD

Completed
N/A
160
RoW
Evaluation of the degree of fibrosis and steatosis, Screening for the components of metabolic syndrome, Measurement of serum semaphorin concentrations, Identification of semaphorin gene polymorphisms
University Hospital for Infectious Diseases, Croatia, Croatian Science Foundation
Non-Alcoholic Fatty Liver Disease, Immune Response, Biomarkers, Liver Fibrosis, Non Alcoholic Steatohepatitis
09/21
03/22
KETONASH, NCT06308757: Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis

Recruiting
N/A
42
Europe
Very-low-calorie ketogenic diet (VLCKD) with meal replacements, Mediterranean low-calorie diet (LCD)
University of Bologna
NASH, NAFLD, Obesity, Liver Fibrosis
11/24
12/26
NCT03695796: French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort)

Recruiting
N/A
1000
Europe
biopsy-proven NAFLD patients with non-invasive tests of liver fibrosis (blood tests, elastography devices) and biobank
University Hospital, Angers
NAFLD
11/24
12/24
HepatoDC, NCT03753308: Mechanism of DCs Dysfunction in Chronic HBV Infection

Recruiting
N/A
132
Europe
Blood Sampling, Liver biopsy
University Hospital, Grenoble, Institut National de la Santé Et de la Recherche Médicale, France, Etablissement Français du Sang
HBV, NASH - Nonalcoholic Steatohepatitis
12/21
12/22
ChiCTR2100048806: Ultrasound Liver Fat Quantification (LFQ) – A Dual-center Study

Not yet recruiting
N/A
 
West China Hospital of Sichuan University; Tianjin Third Central Hospital, Philips (China) Investment Co. Ltd.
non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatosis hepatitis (NASH)
 
 
NASH-ATI, NCT04066400: Role of a Wheat Containing Diet on Non-alcoholic Steatohepatitis

Completed
N/A
40
Europe
Nutritional Intervention
Johannes Gutenberg University Mainz, Goethe University
NASH - Nonalcoholic Steatohepatitis, Diabetes Mellitus, Type 2, Hyperlipidemias
01/22
12/23
ImagingNAFLD, NCT04785937: Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients

Recruiting
N/A
50
Europe
Ultrasound and Magnetic Resonance
Azienda Unità Sanitaria Locale Reggio Emilia
Non-Alcoholic Fatty Liver Disease, Steatohepatitis, Nonalcoholic, Liver Fibroses
01/22
06/22
NCT03151798: The Liver Health Study for Patients With NAFLD

Completed
N/A
336
US
Phase II: Lifestyle treatment, Phase II: Control treatment, Phase I: Observational studies
University of Missouri-Columbia
Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Obesity
03/22
04/23
PASS, NCT05217745: MLCT Oil for Fatty Liver - Trial

Enrolling by invitation
N/A
30
RoW
MLCT Oil, LCT Oil (Corn Oil)
National University Hospital, Singapore, Wilmar International
Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, NAFLD
03/22
03/23
NCT04576923: Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease

Terminated
N/A
36
US
Velacur by Sonic Incytes
Indiana University, Sonic Incytes
NAFLD, NASH - Nonalcoholic Steatohepatitis
04/22
04/22
ADLH, NCT03897218: Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - "A Diet for Liver Health"

Completed
N/A
84
Europe
oatmeal flakes with prebiotic food supplements, millet flakes
RWTH Aachen University
NASH - Nonalcoholic Steatohepatitis
04/22
04/22
TESLA-NASH, NCT04060368: Efficacy and Safety of Endoscopic Sleeve Gastroplasty Versus Laparoscopic Sleeve Gastrectomy in Obese Subjects With NASH

Recruiting
N/A
30
Europe
Endoscopic Sleeve Gastroplasty (ESG) with OverStitch® system + Lifestyle modifications, Laparoscopic Sleeve Gastrectomy (LSG) + Lifestyle modifications
Instituto de Investigación Marqués de Valdecilla
Non-alcoholic Steatohepatitis (NASH)
06/22
06/23
NCT03743272: Repeatability and Reproducibility of Multiparametric MRI

Recruiting
N/A
61
Europe
LiverMultiScan, Multiparametric Magnetic Resonance Imaging (mpMRI)
Perspectum
Liver Diseases, Primary Biliary Cirrhosis, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Cirrhosis, Hemochromatosis, Viral Hepatitis, Autoimmune Hepatitis, Primary Sclerosing Cholangitis
06/22
11/22
ChiCTR2100053645: Ultrasound Liver Fat Quantification on Pediatric Patients

Recruiting
N/A
 
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Philips (China) Investment Co. Ltd.
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatosis hepatitis (NASH)
 
 
iLEAD, NCT04012242: Innovative Liver Elasticity, Attenuation, and Dispersion Ultrasound Study

Recruiting
N/A
400
Europe, Japan, US, RoW
Ultrasound application
Tokyo Medical University
Nonalcoholic Steatohepatitis, Ultrasound, Elastography
07/22
07/22
NCT04341246: Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)

Completed
N/A
28
US
LiverMultiscan, LMS
Perspectum, Food and Drug Administration (FDA)
Non-Alcoholic Fatty Liver Disease
06/23
06/23
NCT04595474: Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Active, not recruiting
N/A
533
US
Transient Elastography
Joslin Diabetes Center
Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Fibrosis, Liver, Type 1 Diabetes, Cirrhosis, Liver
08/22
12/24
NCT03260036: Hepatic Urea Nitrogen Handling in Patients With NASH

Active, not recruiting
N/A
20
Europe
University of Aarhus
Non-Alcoholic Fatty Liver Disease
08/25
08/25
MRI-Detect, NCT04227782: MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH)

Active, not recruiting
N/A
40
Europe
Magnetic Resonance Imaging, magnetic resonance spectroscopy, Stable Isotope Study
University of Oxford
Non-Alcoholic Fatty Liver Disease
10/27
10/27
NCT05052515: The Effects of Natural Extracts Supplementation on NASH Patients

Not yet recruiting
N/A
50
NA
Choline - Vitamin C, E and Ampelopsis Grossedentata natural extracts, Placebo
University of Athens, Laikο General Hospital, Athens
NAFLD
09/22
09/22
NCT04861012: Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt

Not yet recruiting
N/A
360
NA
Ultrasound, Fibroscan
Assiut University
Steatohepatitis, Nonalcoholic
09/22
12/22
NCT05128253: Characterization of the Platelet Inflammatory Response in NAFL and NASH

Recruiting
N/A
44
Europe
High fat meal in a subset of patients with NAFL or NASH
Stefania Basili, University of Roma La Sapienza
NASH - Nonalcoholic Steatohepatitis, NAFLD
09/22
08/23
ChiCTR2000036926: Clinical evaluation of Kuhuang Granules in the treatment of nonalcoholic steatohepatitis

Recruiting
N/A
160
 
Essentiale combined with Kuhuang Granules placebo ;Essentiale combined with Kuhuang Granules
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine; Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai Shenkang Hospital Development Center
nonalcoholic steatohepatitis
 
 
MASH, NCT04009837: Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain

Completed
N/A
184
US
Hip-focused rehabilitation intervention, Spine-focused rehabilitation intervention
University of Delaware, University of Pittsburgh, Duke University, National Institute on Aging (NIA)
Chronic Low-back Pain, Hip Impairments, Hip-spine Syndrome, Osteoarthritis
10/22
10/22
NCT04682600: The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF

Active, not recruiting
N/A
164
US
Liver Incytes System, MRE, MRI PDFF, Fibroscan
Sonic Incytes
Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Liver Fibroses, Liver Steatoses
11/22
07/23
NCT05015491: Effects of Online App Weight Loss Programs on Liver Health in Obese Adults

Completed
N/A
39
US
Noom Healthy Weight Program
Noom Inc., Arizona Liver Health
NASH, Fatty Liver, NAFLD, Weight Loss
09/22
09/22
NCT05370053: The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

Recruiting
N/A
450
US
ELF Test
University of Kansas Medical Center, Gilead Sciences
Fatty Liver, NAFLD
12/22
12/22
ChiCTR1900028204: Effect of UDCA on intestinal microecology in patients with non-obese fatty liver disease

Not yet recruiting
N/A
160
 
UDCA treatment ;placebo ;N/A
Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Zhejiang medical and health research project
nonalcoholic steatohepatitis
 
 
NCT05037890: Effects of Plant Sterols and Stanols on Liver Inflammation

Recruiting
N/A
8
Europe
Margarine
Maastricht University Medical Center, Raisio Group, Unilever R&D, BASF
NASH - Nonalcoholic Steatohepatitis
12/22
12/23
ChiCTR2000029912: Study for the correlation between cognitive impairment and intestinal flora disorder in patients with nonalcoholic fatty liver disease

Not yet recruiting
N/A
90
 
试验组 ;no
Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Zhejiang Province Public Welfare Research Project
nonalcoholic steatohepatitis
 
 
NCT04783116: Plant Stanols and Liver Inflammation in Overweight and Obese Children

Not yet recruiting
N/A
52
Europe
Plant stanols (3g/day), Benecol (Raisio Nutrition Ltd., Raisio, Finland), Placebo
Maastricht University Medical Center
Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Childhood Obesity, Childhood Overweight, Pediatric Obesity
12/22
12/22
ChiCTR2100044996: A randomized controlled clinical trial of polyethylene glycol losartan in the treatment of nonalcoholic steatohepatitis (NASH)

Recruiting
N/A
200
 
Glutathione ;Glutathione+polyethylene glycol losartan
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, self-funded
Nonalcoholic fatty liver disease
 
 
ChiCTR2100046617: A Randomly Controlled Clinical Trial of Electro-acupuncture in Patients with Non-alcoholic Steatohepatitis

Recruiting
N/A
60
 
Electro-acupuncture ;Minimal-acupuncture
Beijing Friendship Hospital, Capital Medical University; Beijing Friendship Hospital, Capital Medical University, self-raised
Non-alcoholic steatohepatitis
 
 
Faraday, NCT06573190: Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B

Completed
N/A
70
RoW
Transient elastography, Fibroscan, Tenofovir Disoproxil Fumarate, TDF
Yaşar Bayındır, MD, Nobel Pharmaceuticals
Chronic Hepatitis B, Hepatic Steatosis
04/23
05/24
Profil-NASH, NCT06152250: Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis

Recruiting
N/A
40
Europe
Liver Fine-Needle Aspiration
Hospices Civils de Lyon
Liver Diseases
01/26
01/26
NCT05044663: Liver and Splenic Stiffness in Predicting Esophageal Varices Needing Treatment in NASH Related Compensated Advanced Chronic Liver Disease.

Completed
N/A
200
RoW
No intervention
Institute of Liver and Biliary Sciences, India
Chronic Liver Disease
02/23
02/23
InLi, NCT03915002: Integrated Approaches for Identifying Molecular Targets in Liver Disease

Completed
N/A
155
US
University of Pittsburgh
Alcoholic Liver Disease, Non-Alcoholic Fatty Liver Disease, Steatohepatitis, Nonalcoholic, Steatohepatitis
04/23
04/23
NCT04043585: Bariatric Surgery on NASH

Completed
N/A
29
Europe
University Hospital, Gentofte, Copenhagen, Gubra ApS
Non-Alcoholic Fatty Liver Disease, Obesity
03/23
03/23
EXPLORER, NCT04165343: Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on

Completed
N/A
81
US
Positron Emission Tomography (PET) on EXPLORER, PET Scan, Magnetic Resonance Imaging, MRI, Echocardiogram and Electrocardiogram, Echo and EKG or ECG, Blood test, Lab test
University of California, Davis
Non-Alcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis (NASH)
05/23
05/23
NCT05065593: The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis

Active, not recruiting
N/A
26
RoW
resistance and aerobic exercise, physical activity recommendation
Hacettepe University
Non-Alcoholic Steatohepatitis
01/24
01/25
ChiCTR2100052845: Evaluation of Effect of Xiaozhi Hugan Capsule on Non-Alcoholic Steatohepatitis: a Randomized Controlled Trial

Not yet recruiting
N/A
124
 
Polyene Phosphatidylcholine Capsule ;Xiaozhi Hugan Capsule
The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine; The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine, Special Project of Traditional Chinese Medicine Scientific Research of He'nan Province (No. 2019JDZX2012)
Non-Alcoholic Steatohepatitis
 
 
ENDONASH, NCT04653311: Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.

Recruiting
N/A
100
Europe
Endomina®
Erasme University Hospital, Epidemiological and Clinical Research Information Network
NASH - Nonalcoholic Steatohepatitis
06/23
12/23
NUTRINAFLD, NCT05946330: Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).

Active, not recruiting
N/A
10
RoW
NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER DISEASE NON-ALCOHOLIC (NAFLD).
Universidade Federal do Paraná
Steatohepatitis, Nonalcoholic, Steatosis, Liver Diseases, Steatohepatitis
06/23
07/24
MHALT, NCT03534141: Mild Hypothermia and Acute Kidney Injury in Liver Transplantation

Terminated
N/A
175
US
Esophageal cooling/warming device, EnsoETM, ECD - Esophageal Cooling Device, Mild hypothermia, Normothermia
University of California, San Francisco, University of Colorado, Denver, The Methodist Hospital Research Institute
Cirrhosis, End Stage Liver Disease, Acute Kidney Injury, Liver Transplant; Complications, Chronic Kidney Diseases, Hepatitis c, Hepatitis B, NASH - Nonalcoholic Steatohepatitis, Alcoholic Cirrhosis, Hepatocellular Carcinoma
08/23
09/23
NCT04820036: A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Active, not recruiting
N/A
20
US
Insulin Resistance, Quality of Life Assessment, Liver Function Test, Radiologic features of NASH, Serologic features of NASH
Brigham and Women's Hospital, American Society for Gastrointestinal Endoscopy, Boston Scientific Corporation
Non-alcoholic Steatohepatitis (NASH), Endoscopic Sleeve Gastroplasty, Non-alcoholic Fatty Liver Disease (NAFLD), Endoscopic Ultrasound, Liver Function, Obesity, Liver Fibroses
09/24
12/24
CORO-NASH, NCT03819283: NASH and Coronary Disease

Recruiting
N/A
260
Europe
Hepatic evaluation
Assistance Publique - Hôpitaux de Paris, Institute of Cardiometabolism and Nutrition, France
Non-Alcoholic Fatty Liver Disease
07/23
07/24
NAFLDIA1, NCT04664036: Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus

Recruiting
N/A
700
Europe
ultrasound, elastography, controlled attenuation parameter (CAP), FLI, FIB-4, NFS
University Hospital, Antwerp
NAFLD, Type 1 Diabetes, Cardiovascular Diseases
07/23
07/25
NCT04389593: Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference

Recruiting
N/A
30
US
University of California, San Diego
Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Liver Fibroses, Liver Inflammation
08/24
08/24
ChiCTR1900025220: The Association of Gut Microbiota With Nonalcoholic Steatohepatitis in Kashgar.

Not yet recruiting
N/A
400
 
N/A ;N/A ;N/A ;N/A
Nanhai hospital, Southern Medical University; Nanhai hospital, Southern Medical University, self-raised
Nonalcoholic steatohepatitis
 
 
ID LIVER, NCT04666402: Integrated Diagnostics for Early Diagnosis of Liver Disease

Recruiting
N/A
1200
Europe
Blood tests for Single Nucleotide Polymorphisms, Faecal microbiome analysis, Serum for diagnostic biomarkers
Manchester University NHS Foundation Trust, University of Manchester, University of Nottingham, Innovate UK
Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Alcoholic Liver Disease, Liver Fibroses
04/25
04/25
POCUS-NASH, NCT05120557: Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Not yet recruiting
N/A
1000
NA
Ultrasound liver assessment, Elastography, Ultrasound attenuation, Sound speed
E-Scopics
Liver Diseases, Liver Cirrhosis, NASH - Nonalcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fibrosis, Liver, Steatosis of Liver
09/23
09/23
NCT05765890: Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

Completed
N/A
675
RoW
No treatment given
Novo Nordisk A/S
Non-alcoholic Steatohepatitis (MASH), Non-alcoholic Fatty Liver Disease (MASLD)
09/23
09/23
MASH, NCT05630521: Testing Feasibility of Medication Adherence Problem Solving for Hypertension

Active, not recruiting
N/A
40
US
Medication Adherence Problem Solving for Hypertension
Rush University Medical Center
Hypertension, Adherence, Medication
08/24
08/24
NCT04591106: Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE

Enrolling by invitation
N/A
190
US
Magnetic resonance imaging (MRI), Magnetic resonance elastography (MRE), Prototype MRE soft flexible passive transducer paddle, MRE transducer paddle
University of California, Los Angeles, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NAFLD, NASH - Nonalcoholic Steatohepatitis
01/25
01/25
NASH, NCT04707651: Formula Diet Treatment for Patients.

Active, not recruiting
N/A
20
Europe
Formula diet
West German Center of Diabetes and Health
Steatohepatitis, Nonalcoholic
12/24
03/25
NCT05935488: Early Liver Disease Breath Detection

Recruiting
N/A
30
Europe
EVOCs emulsion, Selected-ion flow-tube mass spectrometry (SIFT-MS)
Owlstone Ltd, North Norfolk Primary Care Practices, Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
Liver Fibrosis, NASH, Liver Diseases
06/24
06/24
NCT05309642: Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study

Completed
N/A
72
RoW
Intermittent calorie restriction, Standard of care
Ewha Womans University Mokdong Hospital
Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis
12/23
12/23
NCT05792423: Conditionally Increased Output (CIO) Enhanced Ultrasound System

Completed
N/A
22
US
GE ultrasound system with increased acoustic output settings
Massachusetts General Hospital, GE Healthcare
Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Fatty Liver
05/24
05/24
NCT05301231: Omics-based Predictors of NAFLD/Potential NASH

Not yet recruiting
N/A
450
RoW
Genomics (DNA Extraction), Epi-genomics, Proteomics (Glycoproteomics), Salivary Metabolomics, Individualized counselling for behavioural modification
National Research Centre, Egypt
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis
12/23
04/24
NCT04057287: Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)

Recruiting
N/A
670
RoW
No intervention
Institute of Liver and Biliary Sciences, India
Liver Cirrhoses
12/23
12/23
NCT05029583: Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

Recruiting
N/A
5000
Canada
routine screening, physician-driven screening
LMC Diabetes & Endocrinology Ltd.
Nonalcoholic Steatohepatitis, Type 2 Diabetes
10/25
10/25
ChiCTR2100050145: A large sample, multicenter, randomized controlled trial of Xiaomudan in the treatment of nonalcoholic steatohepatitis (spleen deficiency and phlegm and blood stasis)

Not yet recruiting
N/A
500
 
Xiaomu pellets ;Polyene phosphatidylcholine
Affiliated Hospital of Shaanxi University of Chinese Medicine; Department of Science and Technology of Shaanxi Province, Department of Science and Technology of Shaanxi Province
Non-alcoholic Steatohepatitis
 
 
NCT05669677: Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

Active, not recruiting
N/A
233
US
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chronic or Recovered Hepatitis B, Chronic or Recovered Hepatitis C, Chronic or Recovered Hepatitis D, NAFLD, NASH
12/26
12/26
NCT05108415: Development and Validation of a Multi-target, Blood-based NAFLD Diagnosis Test

Not yet recruiting
N/A
1500
NA
HBI Solutions Inc., mProbe Inc.
NAFLD, NASH - Nonalcoholic Steatohepatitis
12/23
12/24
NCT05165446: Novel MRE Technique to Assess a Risk Factor for Liver Cancer

Active, not recruiting
N/A
35
US
Natalie Torok
NASH - Nonalcoholic Steatohepatitis
01/24
03/24
ICAN, NCT04781933: Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH Improvement

Recruiting
N/A
60
Europe
Treatment with Combo, Treatment with placebo
Mativa-Tech SA
NASH - Nonalcoholic Steatohepatitis
01/24
01/25
NCT06423846: Total Intravenous Anesthesia Versus Inhalation Anesthesia on Postoperative Liver Function

Completed
N/A
80
RoW
Total intravenous anesthesia group, TIVA group, sevoflurane group, SEVO group
Benha University
Laparoscopic Sleeve Gastrectomy
05/24
05/24
NCT06195943: Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

Recruiting
N/A
20
US
Exercise Intervention with use of El-Fit App
Milton S. Hershey Medical Center
NASH - Nonalcoholic Steatohepatitis, NASH, Exercise, Liver
03/26
03/26
NCT06552377: Ultrasound and Attenuation Imaging

Completed
N/A
97
Europe
Ultrasound Attenuation imaging measurement
Hywel Dda Health Board
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Fatty Liver, Non-alcoholic Steatohepatitis, Steatosis of Liver
04/24
04/24
NCT06193629: A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar

Recruiting
N/A
150
RoW
Lang Qingata, placebo
Shupei Li
NASH
12/24
12/24
NCT06492369: MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients

Recruiting
N/A
380
RoW
Tanta University
Metabolic- Associated Fatty Liver Disease (MAFLD)
10/24
11/24
NCT06338969: The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis

Recruiting
N/A
150
RoW
Carbohydrate Restriction after a Gastric Bypass, laparoscopic one anastomotic gastric bypass
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
Obesity, Morbid, NASH, Ketosis, Keto Acidosis, Carbohydrate Metabolism Disorder
04/25
08/25
NCT04501042: Investigation on the Role of Gut-liver Axis for Non-alcoholic Steatohepatitis Through Bariatric Surgery

Recruiting
N/A
140
RoW
Bariatric surgery, Liver biopsy, Portal vein sampling
National Taiwan University Hospital, Ministry of Science and Technology, Taiwan
Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Bariatric Surgery
04/24
09/24
VAMOS, NCT05383456: The Visceral Adiposity Measurement and Observation Study

Completed
N/A
196
US
Diagnostic Test, CT Scan, Fibroscan, Urine and Blood testing, HIV Anti-retroviral Background Therapy
Theratechnologies, Dacima Consulting, Medpace, Inc., Vanderbilt University Medical Center, Echosens
HIV, HIV-Infections, HIV-1-infection, HIV I Infection, HIV Lipodystrophy, HIV Infection Primary, HIV-Associated Lipodystrophy, HIV Disease Progression, Lipohypertrophy, Liver Diseases, NAFLD, NASH, Liver Fibrosis, Hepatic Fibrosis, Waist Circumference, BMI, Ectopic Fat, Liver Fat, Hepatic Steatosis
10/23
10/23
NCT06354491: An Imaging-based Quantitative Biomarker Assay for NAFLD in Children

Recruiting
N/A
24
US
Magnetic Resonance Imaging (MRI), Ultrasound (US)
University of Wisconsin, Madison
NAFLD, NASH
04/26
04/27
RedNASH, NCT06519448: Reducing Non-Alcoholic Steatohepatitis

Enrolling by invitation
N/A
30
RoW
Empagliflozin 10 miligrams (mg)
Military University Hospital, Prague
Non-alcoholic Steatohepatitis, Liver Diseases, Diabetes Mellitus, Type 2, Fibrosis, Liver
12/26
12/27
NCT04054310: Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

Recruiting
N/A
225
US
Liver Multi Scan, Biopsy
Perspectum
NASH - Nonalcoholic Steatohepatitis
05/24
05/24
NCT05507151: Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

Recruiting
N/A
30
US
Endoscopic Sleeve Gastroplasty
West Virginia University
Nonalcoholic Fatty Liver Disease
05/24
05/24
NCT03674528: Technical Validation of MR Biomarkers of Obesity-Associated NAFLD

Completed
N/A
152
US
Magnetic Resonance Elastography (MRE), MRI, Liver biopsy, Intraoperative Biopsy
University of Wisconsin, Madison, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), GE Healthcare, Pfizer, Siemens Medical Solutions, National Center for Advancing Translational Sciences (NCATS)
Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis
06/24
06/24
 

Download Options